[Summary] Focusing on technological innovation and product R&D for the treatment
Hangzhou Dejin Medical Technology Co., Ltd. (hereinafter referred to as "Dejin Medical") focuses on the field of interventional treatment of structural heart disease. Founded in Hangzhou in 2015, by the end of 2023 the company had filed over 500 patent applications globally, of which more than 150 have been granted. Three self-developed innovative products have passed the NMPA Special Review Procedure for Innovative Medical Devices. A number of interventional therapeutic devices, represented by the Dragon series, will also greatly enrich China's clinical options in the field of structural heart disease treatment.
Among them, the DragonFly™ Transcatheter Mitral Valve Clip System, as a Chinese self-developed edge-to-edge repair product via transfemoral vein approach, passed the NMPA Special Review Procedure for Innovative Medical Devices in March 2021 and was approved by the NMPA for official marketing in China on November 29, 2023. The product received support from the Ministry of Science and Technology's "14th Five-Year Plan" National Key R&D Program. In addition, marketed products include the Pujiejie™ Medical Radiation Protection Screen, the Magpie™ Balloon Dilatation Catheter, the DragonPath™ Transseptal Puncture System, and the Firework™ Stiff Guidewire Series, among others.
The company is headquartered in the Hangzhou National High-tech Industrial Development Zone (Binjiang District), China, and also has an innovation R&D center in Shenzhen. The enterprise has been recognized as a national and Zhejiang provincial technology-based SME, a Hangzhou High-tech R&D Center, and a Hangzhou Engineering Research Center. In the future, Dejin Medical will adhere to the corporate development strategy of "rooted in China, facing the world," accelerate the incubation of more self-developed devices that address domestic clinical pain points, spare no effort in promoting clinical application, and provide better treatment options for patients in China and around the world.
What does Hangzhou Dejin Medical Technology Co., Ltd. require? Who is Dejin Medical hiring? Dejin Medical recruitment: 医疗卫生/美容保健类占比最多占43.6%，其次是销售类占40.9%. What education can get in at Dejin Medical? 本科占比最多占90.6%，其次是硕士占5.4%. High education required at Dejin Medical? 硕士占5.4%. Work experience required at Dejin Medical? 1-3年占比最多占57.7%，其次是5-10年占18.1%. Where are the job locations at Dejin Medical? 杭州占比最多占21.5%，其次是深圳占21.5%. Based on job postings from the past year, for reference only.
Provided by
Featuring 268 companies ，3 followers
Featuring 94 companies
Featuring 287 companies
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
